{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:24:40Z","timestamp":1649121880061},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGO"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4251\/wjgo.v3.i11.165","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T09:58:52Z","timestamp":1323511132000},"page":"165","source":"Crossref","is-referenced-by-count":0,"title":["Variant angina pectoris associated with FOLFOX4 therapy"],"prefix":"10.4251","volume":"3","author":[{"given":"Hiromichi","family":"Yamane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.1.10"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9930"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947.","DOI":"10.1200\/JCO.2000.18.16.2938"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736"},{"key":"ref6","unstructured":"André T, Tournigand C, Achille E, Tubiana-Mathieu N, Lledo G, Raoul Y, Carola E, Flesch M, Muron T, Boutan-Laroze A. [Adjuvant treatment of colon cancer MOSAIC study's main results]. Bull Cancer 2006;93 Suppl 1:S5-S9."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(05)80072-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn384"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm086"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(03)00399-3"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.113"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032709"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.06.021"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Saif MW, Shah MM, Shah AR. Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 2009;8:191-202.","DOI":"10.1517\/14740330902733961"},{"key":"ref16","unstructured":"Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993;53:3028-3033."},{"key":"ref17","unstructured":"Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma 1998;45:81-82."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.30.871"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H"}],"container-title":["World Journal of Gastrointestinal Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:41:53Z","timestamp":1561056113000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5204\/full\/v3\/i11\/165.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4251\/wjgo.v3.i11.165","relation":{},"ISSN":["1948-5204"],"issn-type":[{"value":"1948-5204","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}